Nazarian, Rosalynn M.
Harvard University · Massachusetts General Hospital
3 papers on CoChatORCID 0000-0003-4003-7193
Most cited papers
- Verified
TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF- Mutant Melanoma
Corcoran, R. B., Rothenberg, S. M., Hata, A. N., Faber, A. C., Piris, A., Nazarian, R. M., Brown, R. D., Godfrey, J. T., Winokur, D., Walsh, J., et al. (2013) · Science Translational Medicine
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 140
- Verified
An Oncogenic Role for ETV1 in Melanoma
Jané-Valbuena, J., Widlund, H. R., Perner, S., Johnson, L. A., Dibner, A. C., Lin, W. M., Baker, A. C., Nazarian, R. M., Vijayendran, K. G., Sellers, W. R., et al. (2010) · Cancer Research
Melanoma and MAPK PathwaysCutaneous Melanoma Detection and Management
Cited by 115
- Verified
Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study
Nazarian, R. M., Prieto, V. G., Elder, D. E., & Duncan, L. M. (2010) · Journal of Cutaneous Pathology
Cutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways
Cited by 65
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free